| SC 13G/A | 2023-02-14 | ARMISTICE CAPITAL, LLC | SPECTRUM PHARMACEUTICALS INC | 17,000,000 | 8.4% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | SPECTRUM PHARMACEUTICALS INC | 8,400,287 | 4.1% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | SPECTRUM PHARMACEUTICALS INC | 7,878,203 | 4.4% | EDGAR |
| SC 13G/A | 2022-03-09 | BlackRock Inc. | SPECTRUM PHARMACEUTICALS INC | 15,854,728 | 9.7% | EDGAR |
| SC 13G/A | 2022-02-15 | ARMISTICE CAPITAL, LLC | SPECTRUM PHARMACEUTICALS INC | 9,665,756 | 5.9% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | SPECTRUM PHARMACEUTICALS INC | 9,492,321 | 5.8% | EDGAR |
| SC 13G | 2022-02-10 | MILLENNIUM MANAGEMENT LLC | SPECTRUM PHARMACEUTICALS INC | 7,619,744 | 4.6% | EDGAR |
| SC 13D | 2022-02-01 | Hanmi Pharmaceutical Co., Ltd. | SPECTRUM PHARMACEUTICALS INC | 15,332,331 | 8.7% | EDGAR |
| SC 13G/A | 2022-01-27 | BlackRock Inc. | SPECTRUM PHARMACEUTICALS INC | 30,215,947 | 18.4% | EDGAR |
| SC 13G/A | 2022-01-25 | BlackRock Inc. | SPECTRUM PHARMACEUTICALS INC | 30,215,947 | 18.4% | EDGAR |
| SC 13G/A | 2022-01-10 | STATE STREET CORP | SPECTRUM PHARMACEUTICALS INC | - | 2.9% | EDGAR |
| SC 13G/A | 2021-10-12 | STATE STREET CORP | SPECTRUM PHARMACEUTICALS INC | - | 10.4% | EDGAR |
| SC 13D/A | 2021-04-30 | SPECTRUM PHARMACEUTICALS INC | CASI Pharmaceuticals, Inc. | 6,886,956 | 4.9% | EDGAR |
| SC 13G/A | 2021-02-16 | ARMISTICE CAPITAL, LLC | SPECTRUM PHARMACEUTICALS INC | 9,592,000 | 6.6% | EDGAR |
| SC 13G | 2021-02-11 | STATE STREET CORP | SPECTRUM PHARMACEUTICALS INC | - | 7.3% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | SPECTRUM PHARMACEUTICALS INC | 12,098,371 | 8.3% | EDGAR |
| SC 13G | 2021-01-25 | BlackRock Inc. | SPECTRUM PHARMACEUTICALS INC | 27,820,979 | 19.1% | EDGAR |
| SC 13D/A | 2020-08-18 | SPECTRUM PHARMACEUTICALS INC | CASI Pharmaceuticals, Inc. | 9,234,315 | 7.5% | EDGAR |
| SC 13G | 2020-08-10 | ARMISTICE CAPITAL, LLC | SPECTRUM PHARMACEUTICALS INC | 7,858,000 | 5.8% | EDGAR |
| SC 13G/A | 2020-02-13 | STATE STREET CORP | SPECTRUM PHARMACEUTICALS INC | - | 4.3% | EDGAR |